Not Signed In -
black haw |
American Sloe; stag bush; sweet viburnum |
Clinical Trial: A Study of the Pharmacokinetics of Black Cohosh
This study is not yet open for patient recruitment.
|
Purpose
Black cohosh is a natural supplement that has been used to treat and prevent menopausal symptoms. Remifemin is a standardized form of black cohosh. The purpose of this study is to determine the levels of components of black cohosh obtained in the blood of healthy women taking Remifemin.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Hot Flashes | Drug: Black cohosh | Phase I |
MedlinePlus related topics: Menopause
Study Type: Interventional
Study Design: Treatment, Non-Randomized, Open Label, Single Group Assignment, Pharmacokinetics Study
Further Study Details:
Expected Total Enrollment: 12
Study start: January 2005
Eligibility
Ages Eligible for Study: 18 Years - 70 Years, Genders Eligible for Study: Female
Accepts Healthy Volunteers
Criteria
Inclusion Criteria:
- No prior diagnosis of cancer other than non-melanoma skin cancer or carcinoma in-situ of the cervix
- No current prescription medication use
- Negative urine pregnancy test OR greater than age 50 with no menses for at least one year OR documented status post hysterectomy
- Competent to understand and sign informed consent
Location Information
Heather S Shaw, MD 919-684-3877 heather.shaw@duke.edu
North Carolina
Duke University Medical Center, Durham, North Carolina, 27710, United States
Study chairs or principal investigators
Heather S Shaw, MD, Principal Investigator, Duke University
More Information
Study ID Numbers: K08 AT001315-01A1
Record last reviewed: September 2004
Last Updated: October 13, 2004
Record first received: September 9, 2003
ClinicalTrials.gov Identifier: NCT00068185
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Record last reviewed: September 2004
Last Updated: October 13, 2004
Record first received: September 9, 2003
ClinicalTrials.gov Identifier: NCT00068185
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
email this page
print this page
bookmark this page
feedback on this page
